期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

抗骨质疏松药对乳腺癌的影响 被引量：2

原文传递
导出
摘要 骨质疏松症和乳腺癌是对患者尤其是女性患者危害极大的疾病，治疗骨质疏松的药物种类繁多，本文综述了抗骨质疏松药降钙素、双膦酸盐、维生素D对乳腺癌的影响。
作者 郭珏函 王守俊
机构地区 郑州大学第一附属医院内分泌及代谢病科
出处 《中国实用医刊》 2014年第6期90-91,共2页 Chinese Journal of Practical Medicine
关键词 骨质疏松症 乳腺癌 降钙素 双膦酸盐 维生素D
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献15

  • 1夏秦.骨质疏松的危害及其防治[J].中华老年医学杂志,2008,27(9):719-720. 被引量：14
  • 2Unnanuntana A, Gladnick BP, Donnelly E, et al. The assessment of fracture risk[J]. J Bone Joint Surg Am,2010,92(3) :743-753.
  • 3Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025 [ J ]. J Bone Miner Res ,2007 ,22 ( 3 ) :465-475.
  • 4梁永俊,周佽想,宇小婷,赵倩.miR-506通过靶向Slug调节上皮间充质转化对乳腺癌细胞侵袭和转移的抑制作用[J].上海交通大学学报（医学版）,2012,32(6):699-705. 被引量：7
  • 5Misa Nakamura, Bo Han, Toshihide Nishishita, et al. Calcitonin tar- gets extracellular sigual-regulated kinase signaling pathway in human cancers [ J ]. J Mol Endocrinol,2007, 39 ( 6 ) : 375-384.
  • 6Nakamura M, Han B, Nishishita T, et al. Calcitonin targets extracel-lular signal-regulated kinase signaling pathway in human cancers [ J ]. J Mol Endocrinol, 2007, 39(6) : 375 - 384.
  • 7洪婷婷,华东.含氮双磷酸盐的抗肿瘤作用[J].国际肿瘤学杂志,2011,38(4):257-260. 被引量：4
  • 8Jagdev SP, Coleman RE, Shipman CM, et al. The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells : evidence for synergy with paclitaxel[ J]. Br J Cancer, 2001,84(8) : 1126-1134.
  • 9Rennert G, Pincher M, Rennert HS, et al. Use of bisphosphonates and risk of postmenopausal breast cancer[ J]. J Chin Oncol, 2010, 28 ( 22 ) : 3577-3581.
  • 10Chlebowski RT, Chen Z, Cauley JA, et al. Oral bisphosphonate use and breast cancer incidence in postmenoparsal women [ J ]. J Chen On- col ,2010,28 (22) :3582-3590.

二级参考文献68

  • 1虞丹.植物雌激素——大豆异黄酮的药理作用研究概况[J].海峡药学,2007,19(2):9-12. 被引量：19
  • 2蔡德山.钙制剂“自强不息”[N].医药经济报.2007-02-05(3).
  • 3国家药典委员会编.中华人民共和国药典《临床用药须知》[S].化学药和生物制品卷.北京:人民卫生出版社.2005.445.
  • 4陈新谦,金有豫,汤光.新编药物学(第十五版)[M].北京:人民卫生出版社,2006.758.
  • 5Tosteson AN, Minshall ME, Shen W, et al. Impact of hip and vertebral fractures on quality adjusted life years. Osteoporos Int, 2001,12 : 1042-1049.
  • 6Gnant M,Eidtmann H.The anti-tumor effect of bisphosphonates ABCSG-12,ZO-FAST and more… Crit Rev Oncol Hematol,2010,74 Suppl 1:S2-6.
  • 7R(a)ikk(o)nen J,M(o)nkk(o)nen H,Auriola S,et al.Mevalonate pathwav intermediates downregulate zoledronic acid-induced isopentenyl pyrophosphate and ATP analog formation in human breast cancer cells.Biochem Pharmacol,2010,79(5):777-783.
  • 8Kogure T,Ueno Y,Kimura O,et al.A novel third generation bisphosphonate,minodronate (YM529),prevented proliferation and migration of hepatocellular carcinoma cells through inhibition of mevalonate pathway.Hepatol Res,2009,39(5):479-489.
  • 9Kubo T,Shimose S,Matsuo T,et al.Inhibitory effects of a new bisphosphonate,minodronate,on proliferation and invasion of a variety of malignant bone tumor cells.J Orthop Res,2006,24 (6):1138-1144.
  • 10Hirata J,Kikuchi Y,Kudoh K,et al.Inhibitory effects of bisphosphonates on the proliferation of human ovarian cancer cell lines and the mechanism.Med Chem,2006,2(3):223-226.

共引文献42

同被引文献63

  • 1余昕航,党雪菲.唑来膦酸预防老年乳腺癌患者阿那曲唑所致骨质疏松的疗效[J].中国老年学杂志,2014,34(11):3162-3163. 被引量：9
  • 2Buttgereit FR, Iipworth BJ. Optimised glucocorticoid therapy:the sharpe- ning of an old spear[ J~. Lancet,2005,365 (9461) :801-803.
  • 3Den Uyl DE, Lems WF. Advances in glucocorticoid-induced osteoporosis[J]. Curr Rheumatol Rep ,2011,13 (3) :233-240.
  • 4Stewart PM, Krozowski ZS. 11 beta-hydroxysteroid dehydrogenase [ J 1. Vitam Horm, 1999, 57:249-324.
  • 5Mckay LI, Cidlowski JA.Cross-talk between nuclear factor-kappa B and the steroid hormone receptors : mechanisms of mutual antagonism [ J ]. Mol Endocrinol, 1998,12 ( 1 ) :45-56.
  • 6Vayssiere BM, Dupont S, Choquart A, et al. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiin- flammatory activity in vivo[ J ]. Mol Endocrinol, 1997, 11 (9) :1245- 1255.
  • 7Buttgereit F, Straub RH, Wehling M, et al. Glucocorticoids in the treat- ment of rheumatic diseases: an update on the mechanisms of action [ J ]. Arthritis Rheum ,2004,50 ( 11 ) :3408-3417.
  • 8Aulakh R, Singh S. Strategies for minimizing corticosteroid toxicity: a review [ J 1. Indian J Pediatr,2008,75 (10) : 1067-1073.
  • 9Curtis JR,Westfall AO, Allison J, et al. Population-based assessment of adverse events associated with long-term glucoeorticoid use [ J ]. Arthritis Rheum ,2006,55 ( 3 ) :420-426.
  • 10Cushing, H. The basophil adenomas of the pituitary body and their clini- cal manifestations ( pituitary basophilism) [ J ]. Obes Res, 1994,2 ( 5 ) : 486-508.

引证文献2

二级引证文献26

中国实用医刊
2014年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部